Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, Phase IIIB Trial) - Bovill, EG; Tracy, RB; Knatterud, GL; Stone, PG; Nasmith, J; Gore, JM; Thompson, BW; Tofler, GH; Kleiman, NS; Cannon, C; Braunwald, E (Am J Cardiol, 1997)